Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection with the Delta VariantCELLSIF5.22024-01-233OAAI
Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infectionLIFE SCIENCE ALLIANCEIF2.92023-04-118OAAI
Immunoglobulin G subclasses confer protection against Staphylococcus aureus bloodstream dissemination through distinct mechanisms in mouse modelsPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12023-03-275OAAI
Comparison of Metagenomic Sequencing and the NanoString nCounter Analysis System for the Characterization of Bacterial and Viral Communities in Vaginal SamplesMSPHEREIF3.12022-10-261OAAI
SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived CellsMBIOIF4.72022-10-2616OAAI
A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targetsNATURE BIOTECHNOLOGYIF41.72022-10-1082OA
Longitudinal Dynamics of Skin Bacterial Communities in the Context of Staphylococcus aureus DecolonizationMICROBIOLOGY SPECTRUMIF3.82022-04-273OAAI
Spherical nucleic acids as an infectious disease vaccine platformPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12022-03-2122OAAI
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responsesSCIENCE ADVANCESIF12.52022-02-2581OAAI